1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.Resectable Gastric and Gastroesophageal Junction AdenocarcinomaActive, not recruitingPhase 22025-09-10NCT03773367